Glucagon for Beta Blocker Overdose: Technical Pros and Cons
Published: July 15, 2026 14:29
Author: Simone Garcia
Abstract: Glucagon, a 29-amino acid peptide, serves as a critical antidote for beta-blocker overdose by bypassing blocked receptors to stimulate cardiac contractility via cAMP. Technical pros include rapid onset and efficacy in refractory bradycardia; cons involve short half-life, hyperglycemia risk, and limited stability. The peptide market shows 8.2% CAGR growth, with brands like Novo Nordisk’s GlucaGen and Eli Lilly’s Baqsimi dominating. Product parameters (e.g., 1 mg IV/IM) and cold-chain logistics (2–8°C) are vital. Regulatory certifications (FDA, EMA) ensure quality. Selection prioritizes purity >95% and reconstitution stability.